GASTRIC INHIBITORY POLYPEPTIDE (GIP) AS A POTENTIAL BIOMARKER OF NUTRITIONAL RESILIENCE IN ACUTE ILLNESS: A SECONDARY ANALYSIS OF THE RANDOMIZED CLINICAL TRIAL EFFORT